DEVELOGEN AG
Develogen is a biology-driven drug discovery company that is engaged in the development of therapies for diabetes and obesity. The company was founded in 1995 and is based in Georgia, United States.
DEVELOGEN AG
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
1997-01-01
Address:
Göttingen, Niedersachsen, Germany
Country:
Germany
Website Url:
http://www.develogen.com
Total Employee:
11+
Status:
Active
Contact:
+49551505580
Total Funding:
61.53 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2003-11-20 | Peptor | Peptor acquired by Develogen AG | N/A |
| 2000-11-15 | HepaVec AG | HepaVec AG acquired by Develogen AG | N/A |
Investors List
Thuja Capital
Thuja Capital investment in Venture Round - Develogen AG
Office of the Chief Scientist
Office of the Chief Scientist investment in Grant - Develogen AG
Omega Funds
Omega Funds investment in Venture Round - Develogen AG
AlpInvest Partners
AlpInvest Partners investment in Series C - Develogen AG
Deutsche Venture Capital
Deutsche Venture Capital investment in Series B - Develogen AG
Dresdner Kleinwort Capital
Dresdner Kleinwort Capital investment in Series B - Develogen AG
DKA Capital
DKA Capital investment in Series B - Develogen AG
Global Life Science Ventures
Global Life Science Ventures investment in Series B - Develogen AG
Techno Venture Management
Techno Venture Management investment in Series B - Develogen AG
Atlas Venture
Atlas Venture investment in Series A - Develogen AG
Official Site Inspections
http://www.develogen.com
- Host name: 172.67.171.177
- IP address: 172.67.171.177
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
